Aridis Pharmaceuticals Inc Sustainability Reports
Aridis Pharmaceuticals is a biopharmaceutical company focused on the development of novel, differentiated antibody therapies (mAbs) for life-threatening infectious diseases, including hospital-acquired pneumonia.
Sector: Manufacturing
Country: United States
Exchange: OTC Markets
FIGI: BBG005TNS201
2 reports from 2018 to 2020
